Physician profile
Robert A Milam
NPI 1881676682
$24,458.37
in general payments reported to CMS, 2019-2025
23 companies · $439 in 2025
The $439 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,013 · 2020: $10K · 2021: $3,867 · 2022: $1,805 · 2023: $2,292 · 2024: $686 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,284 · Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,284.22 |
| Food and Beverage | $1,132.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $8,679.12 | 2019-2020 | |
| Stryker Corporation | $5,261.95 | 2021-2023 | Everest Spinal System, Yukon Oct Spinal System, Serrato |
| Medical Device Business Services, INC. | $2,925.00 | 2019 | |
| Cutting Edge Spine, LLC | $2,719.71 | 2019-2020 | |
| Globus Medical, INC. | $1,281.89 | 2023-2025 | Excelsiusgps Robotic Navigation System, Legacy Stelkast Knee, Excelsius Gps |
| Orthofix Medical, INC. | $1,105.93 | 2019-2023 | Physio-Stim, Spinal-Stim, Sfs |
| Nuvasive, INC. | $533.38 | 2019-2022 | |
| Medtronic, INC. | $507.38 | 2022-2025 | Mazor X System |
| Depuy Synthes Sales INC. | $333.76 | 2019-2025 | Velys |
| Synthes Gmbh | $250.00 | 2022 | |
| Cerapedics INC. | $245.30 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Alphatec Spine, INC | $162.75 | 2021 | |
| Relievant Medsystems, INC. | $153.85 | 2021 | |
| Intrinsic Therapeutics | $145.46 | 2022 | |
| Medicrea USA, Corp. | $35.95 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $33.11 | 2021 | |
| Spine Wave, INC. | $24.00 | 2022 | |
| Radius Health, INC. | $18.79 | 2022 | |
| Theragen, INC. | $15.29 | 2023 | Actastim-S |
| Zyla Life Sciences, INC. | $13.07 | 2019 | |
| Pfizer INC. | $12.68 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Milam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.